In his final moments, Alex Pretti did what nurses are educated to do, a nurse writes. He noticed, cared, and responded to an ...
UnitedHealth took a $1.6 billion charge, net of taxes, in the fourth quarter of 2025 that reflected final costs from the 2024 ...
Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn’t studying weight loss. Roche plans to launch Phase 3 studies of its ...
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
U.K. health officials are facing pressure to rethink how they expand the list of diseases that all newborns are screened for ...
ICE protests in Minneapolis might seem unrelated to NIH funding, cancer screening coverage, and PBM reforms, but indeed they are connected.
When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...
Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting Tuesday that the drug led ...
The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...
The Trump administration plans to increase payments to next year’s Medicare Advantage plans by less than 0.1% on average — ...
Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial ...
The qualified medical experts, the pseudoscientific entertainers, and the MAHA mobilizers leading online health content today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results